Beijing Centre Biology Co.
Latest round
- Series C
Last raised
- Jun 2015
Total raised
- $22M
Investors
- 4
About Beijing Centre Biology Co.
, Ltd operates in the health supplement sector, specializing in the production of Astragalus polysaccharide powder, the only company in the industry licensed to manufacture this product. Founded in Beijing, China, the company's CEO is Housheng Jiang., Ltd specializes in producing Astragalus polysaccharide powder, which is derived from the Astragalus plant, recognized for its potential health benefits, including immune support and anti-inflammatory properties. The company's primary offerings cater to various industries, notably dietary supplements and functional foods, addressing the needs of health-conscious consumers and businesses globally., Ltd generates revenue through direct sales of its flagship Astragalus polysaccharide powder to clients in the health supplement and natural food sectors. The sales process is conducted on a B2B basis, with bulk order placements structured around contractual agreements. The company aims to expand its market presence into North America and Europe by the end of 2016, capitalizing on trends in natural health solutions. Additionally, they are exploring entry into the Southeast Asian market to meet increasing consumer demand for natural products.
Who invested in Beijing Centre Biology Co.
4 investors across 3 rounds
See all investors in Beijing Centre Biology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Beijing Centre Biology Co.
Who invested in Beijing Centre Biology Co.?
Beijing Centre Biology Co. has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beijing Centre Biology Co. raised?
Beijing Centre Biology Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Beijing Centre Biology Co. last raise money?
Beijing Centre Biology Co.'s most recent round on record is a Series C, in Jun 2015.
What does Beijing Centre Biology Co. do?
, Ltd operates in the health supplement sector, specializing in the production of Astragalus polysaccharide powder, the only company in the industry licensed to manufacture this product.
Where is Beijing Centre Biology Co. headquartered?
Beijing Centre Biology Co. is headquartered in Beijing, China.
Which VCs invest in companies like Beijing Centre Biology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Beijing Centre Biology Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Beijing Centre Biology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.